CELLDEX THERAPEUTICS INC (CLDX) Stock Balance Sheet
NASDAQ:CLDX - Nasdaq - US15117B2025 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 17.14M | 28.36M | 34.81M | 29.40M | 39.10M | |||
| Marketable Securities | 656.15M | 696.92M | 388.78M | 275.50M | 369.10M | |||
| Receivables | 1.06M | 700.00K | 2.63M | 300.00K | 200.00K | |||
| Other Current Assets | 19.40M | 21.18M | 5.47M | 12.40M | 2.40M | |||
| Total Current Assets | 693.76M | 747.16M | 431.69M | 317.70M | 410.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 8.12M | 8.24M | 6.64M | 7.70M | 6.50M | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 27.19M | 27.19M | 27.19M | 27.20M | 27.20M | |||
| Other Non-Current Assets | 10.41M | 9.75M | 107.00K | 100.00K | 100.00K | |||
| Total Non-Current Assets | 45.71M | 45.18M | 33.93M | 35.00M | 33.90M | |||
| TOTAL ASSETS | 739.47M | 792.34M | 465.63M | 352.70M | 444.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 26.95M | 35.29M | 23.64M | 14.30M | 13.70M | |||
| Accounts Payable | 3.41M | 3.27M | 3.49M | 3.30M | 1.20M | |||
| Other Current Liabilities | 1.65M | 942.00K | 3.99M | 1.00M | 1.60M | |||
| Total Current Liabilities | 32.02M | 39.50M | 31.13M | 18.60M | 16.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 4.47M | 5.83M | 5.33M | 7.90M | 8.70M | |||
| Total Non-Current Liabilities | 4.47M | 5.83M | 5.33M | 7.90M | 8.70M | |||
| TOTAL LIABILITIES | 36.49M | 45.34M | 36.46M | 26.50M | 25.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.61B | -1.56B | -1.40B | -1.26B | -1.14B | |||
| Additional Paid In Capital | 2.31B | 2.30B | 1.82B | 1.58B | 1.56B | |||
| Common Shares | 66.00K | 66.00K | 56.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 2.60M | 2.60M | 2.60M | 2.60M | 2.60M | |||
| Shares Outstanding | 66.38M | 66.37M | 55.88M | 47.20M | 46.70M | |||
| Tangible Book Value per Share | 10.18 | 10.84 | 7.19 | 6.33 | 8.40 | |||
| Total Shareholders' Equity | 702.98M | 747.00M | 429.17M | 326.20M | 419.50M | |||
| TOTAL LIABILITIES AND EQUITY | 739.47M | 792.34M | 465.63M | 352.70M | 444.70M | |||
| Statistics | ||||||||
| Current Ratio | 21.67 | 18.91 | 13.87 | 17.08 | 24.90 | |||
| Return On Assets (ROA) | -24.19% | -19.92% | -30.37% | -31.85% | -15.86% | |||
| Return On Equity (ROE) | -25.44% | -21.13% | -32.95% | -34.44% | -16.81% | |||
All data in USD , ROIC based on taxRate of 0.21